Artia Global Partners LP Rapt Therapeutics, Inc. Transaction History
Artia Global Partners LP
- $498 Billion
- Q1 2024
A detailed history of Artia Global Partners LP transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 137,308 shares of RAPT stock, worth $383,089. This represents 0.25% of its overall portfolio holdings.
Number of Shares
137,308
Previous 19,638
599.2%
Holding current value
$383,089
Previous $488 Million
152.67%
% of portfolio
0.25%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
147Shares Held
29.2MCall Options Held
709KPut Options Held
1.06M-
Column Group LLC San Francisco, CA2.68MShares$7.48 Million15.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$6.96 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$6.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.03MShares$5.66 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.91MShares$5.32 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $82.7M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...